by ComplianceQuest

My Dashboard Inspection Tracker FDA Guidance Templates Assessments

Sign in Get started

Tracker Overview Enforcement Themes Form 483s Warning Letters Inspections Recalls Investigators Companies Facilities

ANALYTICS

Tracker Overview Enforcement Themes

FDA ACTIONS

Form 483s Warning Letters Inspections Recalls

AUDIT READINESS

COMPANIES

Companies Facilities

Loading…

Dashboard Warning LettersWarning Letter Details

Fareva Morton Grove Warning Letter Details

Warning Letter

Fareva Morton Grove

1 Avenue President Wilson 75016 Paris France

Issue DateMarch 03, 2026

FEI Number1410794

Violations3

CountryFrance

Issuing Office

Center for Drug Evaluation and Research (CDER)

Product Type

Drugs

Status

Open

Subject

CGMP/Finished Pharmaceuticals/Adulterated

Fareva Morton Grove FDA Warning Letter, March 3, 2026